郭伟圣，广州医科大学生物医学工程学院教授、博导，入选教育部青年长江学者，国家重点研发计划青年科学家，中国科协青年托举人才，广东省杰青。郭教授曾担任国家自然科学基金委医学部流动项目主任（2021-2023年），现担任中国生物材料学会纳米生物材料分会秘书长兼委员。主要围绕“微环境免疫调控型纳米载体系统”开展研究开发了一系列免疫调控型纳米载体系统用于肿瘤免疫、自身免疫耐受、心血管免疫等治疗研究。主持承担国家重点研发计划项目、国自然区域联合重点、面上和青年等国家和省部级科研项目15项，以通讯作者在 Nature Nanotechnology，Science Advances，Nature Communications，Nature Review Bioengineering，Advanced Materials等国际著名期刊上发表学术论文60余篇，影响因子大于 10 的高水平研究论文40余篇，论文总被引超7000次。荣获中华医学会青年科技奖，阿里巴巴“青橙优秀入围奖”、广东省药理学会科技成果奖一等奖、天津市自然科学奖一等奖，申请国家发明专利13项。
Dr. Weigang Guo is a Professor and Doctoral Supervisor at the School of Biomedical Engineering, Guangzhou Medical University. He has been recognized as a Young Changjiang Scholar by the Ministry of Education, a Young Scientist under the National Key R&D Program, a recipient of the Young Elite Scientist Sponsorship Program by the China Association for Science and Technology, and an Outstanding Young Scholar of Guangdong Province. Dr. Guo previously served as a rotating program director at the Department of Medical Sciences, National Natural Science Foundation of China (2021–2023). He currently holds the position of Secretary-General and Committee Member of the Division of Nano-Biomaterials at the Chinese Society for Biomaterials. Dr. Guo's research focuses on Microenvironment-Immunomodulatory Nanocarrier Systems, with applications in tumor immunotherapy, autoimmune tolerance, and cardiovascular immunity. He has led 15 national and ministerial level research projects, including the National Key R&D Program of China, NSFC Regional Joint Key Project, National Natural Science Foundation of China and National Science Fund for Distinguished Young Scholars of China. As the corresponding author, he has published over 60 articles in prestigious international journals covering Nature Nanotechnology, Science Advances, Nature Communications, Nature Review Bioengineering, and Advanced Materials, including more than 40 papers with an impact factor greater than 10, accumulated over 7,000 citations. He has received awards including the Youth Science and Technology Award from the Chinese Medical Association, the Alibaba DAMO Academy Young Scientist Finalist Award, the First Prize of Science and Technology Achievement Award from the Guangdong Pharmacological Society, and the First Prize of Tianjin Natural Science Award. He has filed 13 national invention patents.
E-mail: tjuguoweisheng@126.com